NO304738B1 - Acylerte aminoalkanimidazoler og -triazoler, farmasoeytisk preparat inneholdende disse samt anvendelse av for bindelsene for fremstilling av farmasoeytiske preparater - Google Patents

Acylerte aminoalkanimidazoler og -triazoler, farmasoeytisk preparat inneholdende disse samt anvendelse av for bindelsene for fremstilling av farmasoeytiske preparater

Info

Publication number
NO304738B1
NO304738B1 NO951944A NO951944A NO304738B1 NO 304738 B1 NO304738 B1 NO 304738B1 NO 951944 A NO951944 A NO 951944A NO 951944 A NO951944 A NO 951944A NO 304738 B1 NO304738 B1 NO 304738B1
Authority
NO
Norway
Prior art keywords
pharmaceutical preparations
compounds
triazoles
preparation
aminoalkanimidazoles
Prior art date
Application number
NO951944A
Other languages
English (en)
Norwegian (no)
Other versions
NO951944D0 (no
NO951944L (no
Inventor
Ingeborg Schuster
Helmut Egger
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of NO951944D0 publication Critical patent/NO951944D0/no
Publication of NO951944L publication Critical patent/NO951944L/no
Publication of NO304738B1 publication Critical patent/NO304738B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Lubricants (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Emulsifying, Dispersing, Foam-Producing Or Wetting Agents (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
NO951944A 1994-05-18 1995-05-16 Acylerte aminoalkanimidazoler og -triazoler, farmasoeytisk preparat inneholdende disse samt anvendelse av for bindelsene for fremstilling av farmasoeytiske preparater NO304738B1 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9409882A GB9409882D0 (en) 1994-05-18 1994-05-18 Organic compounds

Publications (3)

Publication Number Publication Date
NO951944D0 NO951944D0 (no) 1995-05-16
NO951944L NO951944L (no) 1995-11-20
NO304738B1 true NO304738B1 (no) 1999-02-08

Family

ID=10755289

Family Applications (1)

Application Number Title Priority Date Filing Date
NO951944A NO304738B1 (no) 1994-05-18 1995-05-16 Acylerte aminoalkanimidazoler og -triazoler, farmasoeytisk preparat inneholdende disse samt anvendelse av for bindelsene for fremstilling av farmasoeytiske preparater

Country Status (30)

Country Link
US (1) US5622982A (fr)
EP (1) EP0683156B1 (fr)
JP (1) JP2912566B2 (fr)
KR (1) KR100371465B1 (fr)
CN (1) CN1060163C (fr)
AT (1) ATE164576T1 (fr)
AU (1) AU696880B2 (fr)
BR (1) BR9502062A (fr)
CA (1) CA2149459C (fr)
CO (1) CO4290423A1 (fr)
CZ (1) CZ285385B6 (fr)
DE (1) DE69501915T2 (fr)
DK (1) DK0683156T3 (fr)
ES (1) ES2114289T3 (fr)
FI (1) FI112364B (fr)
GB (1) GB9409882D0 (fr)
GR (1) GR3026505T3 (fr)
HK (1) HK1008743A1 (fr)
HU (1) HUT72063A (fr)
IL (1) IL113743A (fr)
MY (1) MY135559A (fr)
NO (1) NO304738B1 (fr)
NZ (1) NZ272129A (fr)
PE (1) PE14896A1 (fr)
PH (1) PH31510A (fr)
RU (1) RU2152933C2 (fr)
SI (1) SI0683156T1 (fr)
SK (1) SK280326B6 (fr)
TW (1) TW351718B (fr)
ZA (1) ZA954074B (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0708771T3 (da) * 1993-07-15 1999-06-21 Pfizer Benzyloxyquinuclidiner som substans P antagonister
WO1997018817A1 (fr) * 1995-11-20 1997-05-29 Kiyoshi Kita Preparation externe contenant de la vitamine d ou de la vitamine k
WO1998053806A1 (fr) * 1997-05-26 1998-12-03 New Vision Co., Ltd. Compositions medicinales a administration topique renfermant les vitamines d et les vitamines k
US6034251A (en) * 1997-11-07 2000-03-07 Schering Corporation Phenyl-alkyl-imidazoles
TW575562B (en) * 1998-02-19 2004-02-11 Agrevo Uk Ltd Fungicides
CN1114593C (zh) * 1998-05-08 2003-07-16 陶氏益农有限责任公司 2位被取代的吡啶的制备
GB0029524D0 (en) * 2000-12-04 2001-01-17 Univ Sheffield Disease treatment
GB0128415D0 (en) * 2001-11-27 2002-01-16 Univ Sheffield Medicaments
US7429604B2 (en) * 2004-06-15 2008-09-30 Bristol Myers Squibb Company Six-membered heterocycles useful as serine protease inhibitors
WO2006036892A2 (fr) * 2004-09-24 2006-04-06 Sapphire Therapeutics, Inc. Utilisation d'inhibiteurs de 24-hydroxylase dans le traitement du cancer
WO2006032299A1 (fr) * 2004-09-24 2006-03-30 Susanna Miettinen Utilisation d'inhibiteurs de 24-hydroxylase dans le traitement d'un cancer
CN104530038A (zh) * 2014-12-10 2015-04-22 沈阳药科大学 酰胺咪唑类衍生物及其用途

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2041771C3 (de) * 1970-08-22 1979-07-26 Bayer Ag, 5090 Leverkusen derivate
US4191767A (en) * 1977-01-07 1980-03-04 Westwood Pharmaceuticals, Inc. Method for treating fungal infection in mammals with imidazo [1,2-a]quinoxalines
CH655103A5 (de) * 1983-03-11 1986-03-27 Sandoz Ag Azolderivate, verfahren zu ihrer herstellung und ihre verwendung.
CH677925A5 (fr) * 1986-12-03 1991-07-15 Sandoz Ag

Also Published As

Publication number Publication date
KR950032147A (ko) 1995-12-20
PE14896A1 (es) 1996-05-09
EP0683156B1 (fr) 1998-04-01
FI952383A0 (fi) 1995-05-16
SI0683156T1 (en) 1998-06-30
CO4290423A1 (es) 1996-04-17
DE69501915D1 (de) 1998-05-07
SK280326B6 (sk) 1999-11-08
EP0683156A1 (fr) 1995-11-22
HK1008743A1 (en) 1999-05-14
NO951944D0 (no) 1995-05-16
HUT72063A (en) 1996-03-28
CN1060163C (zh) 2001-01-03
FI112364B (fi) 2003-11-28
JPH0853422A (ja) 1996-02-27
TW351718B (en) 1999-02-01
DK0683156T3 (da) 1998-10-19
MY135559A (en) 2008-05-30
ZA954074B (en) 1996-11-18
DE69501915T2 (de) 1998-08-27
AU696880B2 (en) 1998-09-24
SK63595A3 (en) 1995-12-06
KR100371465B1 (ko) 2003-03-19
ATE164576T1 (de) 1998-04-15
BR9502062A (pt) 1996-04-30
RU2152933C2 (ru) 2000-07-20
PH31510A (en) 1998-11-03
HU9501451D0 (en) 1995-06-28
ES2114289T3 (es) 1998-05-16
CA2149459C (fr) 2006-09-19
IL113743A0 (en) 1995-08-31
NO951944L (no) 1995-11-20
FI952383A (fi) 1995-11-19
US5622982A (en) 1997-04-22
NZ272129A (en) 1996-05-28
CN1120039A (zh) 1996-04-10
AU2008995A (en) 1995-11-23
JP2912566B2 (ja) 1999-06-28
IL113743A (en) 1999-08-17
GR3026505T3 (en) 1998-07-31
CZ285385B6 (cs) 1999-07-14
RU95107652A (ru) 1997-03-20
GB9409882D0 (en) 1994-07-06
CZ126595A3 (en) 1995-11-15
CA2149459A1 (fr) 1995-11-19

Similar Documents

Publication Publication Date Title
NO308798B1 (no) Proteinkinase-C-hemmere, anvendelse av samme for fremstilling av farmasøytika samt farmasøytisk formulering omfattende samme
NO971471L (no) Nye karboksamider med fungicid aktivitet
CY1112084T1 (el) Παραγωγα 5-φαινυλθειαζολης και χρηση ως αναστολεις της κινασης ρi3
RU2088589C1 (en) Derivatives of 17 beta-substituted-4-aza-5-5 alpha-androstane-3-ones, methods of synthesis of compounds, pharmaceutical composition, compound 4
NO304738B1 (no) Acylerte aminoalkanimidazoler og -triazoler, farmasoeytisk preparat inneholdende disse samt anvendelse av for bindelsene for fremstilling av farmasoeytiske preparater
RU95111308A (ru) Производные 2-амино-4-фенил-4-оксомасляной кислоты, способы получения, фармацевтическая композиция
NO308302B1 (no) Tetrahydropyranderivativer, farmasøytisk preparat inneholdende slike derivater samt anvendelse derav
NO308607B1 (no) Kjemisk forbindelse, et farmasøytisk preparat inneholdende denne, samt anvendelse av forbindelsen til fremstilling av en blodplateaggregeringsinhibiotor og fremstilling av et farmasøytisk preparat til behandling eller forebygging av trombotiske
NO303578B1 (no) Anvendelse av 2,3-trans-disubstituerte tropanforbindelser for fremstilling av medikamenter, samt slike forbindelser og farmas°ytiske preparater som omfatter dem
NO923983L (no) Bisfenyletanderivater, fremgangsmaate for deres fremstilling og farmasoeytiske preparater derav
HUP9801596A3 (en) Use of azole compounds for preparing pharmaceutical compositions useful for the treatment of fungal infections, new azole derivatives and pharmaceutical compositions containing them
DK669388D0 (da) Azolderivater
DE69905524D1 (de) 8H-(2,3-b)-Pyrrolozin-8-one Derivate, Verfahren zur ihre Herstellung und sie enthaltende pharmazeutische Zusammensetzungen

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees